6, May 2024
Fortis Hospital Bannerghatta’s Breakthrough: Treating 87-Year-Old’s Severe Heart Blockages

Anantapur, 6th May 2024: Fortis Hospital Bannerghatta Road, Bengaluru, successfully treated Mr. Reddy, an 87-year-old resident from Anantapur, who experienced severe breathlessness and chest pain. These symptoms led to the diagnosis of critical heart blockages caused by calcium deposits. Dr. Srinivas Prasad BV, Consultant-Interventional Cardiology, Fortis Hospital, Bannerghatta Road, Bengaluru, used the state-of-the-art Intravascular Lithotripsy (IVL) technology to address the complexities of Mr. Reddy’s condition. This innovative technique breaks down the calcium while minimizing vessel wall trauma allowing the surgery to be completed efficiently within 45 minutes. Mr. Reddy was able to go home just three days following the procedure, marking another success in advanced cardiac care by Fortis Hospital Bannerghatta.

Mr. Reddy

Mr. Reddy was referred to Fortis Hospital Bannerghatta due to the unavailability of the required resources in Anantapur to perform the surgery. After a comprehensive evaluation, it was revealed that Mr. Reddy had experienced a mild heart attack caused by the calcific blockages in his coronary arteries. The blockages led to chest pain and breathlessness, impacting his daily activities. Given the urgency and complexity of his case, Dr. Srinivas Prasad BV opted for a minimally invasive procedure called percutaneous coronary intervention (PCI) to open the blocked arteries and restore normal blood flow. This procedure was complemented using Intravascular Lithotripsy (IVL) technology, which efficiently breaks down the calcium deposits while minimizing damage to the vessel wall.

Dr Srinivas Prasad BV, consultant – Interventional Cardiology, Fortis Hospital, Bannerghatta Road, Bengaluru, emphasized the necessity of employing advanced technology over conventional methods. He stated, “The patient had calcium deposits in the heart, which complicated the feasibility of conventional angioplasty (a procedure used to widen narrowed or blocked blood vessels to improve blood flow). Therefore, we opted to proceed with Percutaneous Coronary Intervention (PCI) and Intravascular Lithotripsy (IVL) to open the blocked arteries, restore normal blood flow, and crush the calcium deposits. Following the crushing of the calcium deposits, a balloon was inserted into the artery to open the arterial blocks, and a stent (a small, metal mesh tube) was placed inside the blockages to help keep them open.”

Thanking the medical team Mr Reddy (Patient) said. “I am immensely grateful to Dr. Srinivas Prasad and the entire team at Fortis Hospital Bannerghatta for their exceptional care and expertise. Their dedication and skill restored my health and provided me with reassurance and comfort throughout my journey. I cannot thank them enough for the support, care, and life-saving treatment they provided.”

Mr. Akshay Oleti, Business Head, Fortis Hospitals, Bengaluru, said, “We are deeply gratified to have been able to offer Mr. Ramesh the highest standard of care, leveraging our state-of-the-art facilities and expertise in cardiac interventions. By employing advanced technologies like Intravascular Lithotripsy (IVL), we could navigate the complexities of his condition with precision and efficacy. This successful ou

4, May 2024
ASG Eye Hospitals Completes the Acquisition of Vasan Eye Care

ASG Eye Hospitals Completes the Acquisition of Vasan Eye Care, Introduces New Initiatives in ASG Vasan Eye Hospitals in Kerala

Kochi, 04 May, 2024: ASG Eye Hospitals completed the acquisition of Vasan Eye Care Hospitals and introduced new initiatives in ASG Vasan Eye Hospitals in Kerala. ASG Vasan Eye Hospitals, Kerala introduced advanced eye care services for all eye-related problems. With the acquisition of Vasan Eye Care, the network of ASG Eye Hospitals have increased to over 150 across India with presence in 21 states and 83 cities with 600 + Eye Specialists across India.

The hospital offers comprehensive eye care services covering all areas of eye specialization. Patients can now benefit from premium intraocular lenses such as Toric, Multifocal, EDOF, Trifocal ensuring the highest quality vision correction available. The state-of-the-art facilities, all specialized doctors, and state-of-the-art machines adhere to international standards, providing patients with a comfortable and advanced environment for their eye care needs.

The ASG Vasan Eye Care hospital at Kochi has a team of highly skilled doctors led by Dr. Sony George, Senior Consultant, Head of Cataract and Refractive Surgery, Vasan Eye Care Hospital-Kochi, and Thrissur. The other team includes Dr. Sreeshankar -CMO, Dr. Amita Nair -Medical Retina, and Dr. Hima Jos Cataract and Glaucoma Surgeon.

ASG Vasan Eye Hospital emerges with an enhanced focus on delivering high-tech and affordable ophthalmic care. The ASG Vasan Eye Hospitals in Kerala feature comprehensive eye care services, including cataract surgery, Refractive surgery, vision rehabilitation services, Neuro-ophthalmology, Uveitis, retina, glaucoma, cornea and oculoplasty services, and more. The hospital also provides specialized care round-the-clock, including emergency eye treatments in all the centres with the advanced infrastructures.

ASG Vasan Eye Care has centres spread across major districts in Kerala such as Trivandrum, Kottayam, Thrissur, and Calicut. The hospital accepts all insurances and is empanelled with Ex-Servicemen Contributory Health Scheme (ECHS), ensuring accessible eye care for all. ASG Eye Hospitals, has served over 7.5 million people through its 54 state-of-the-art specialty eye care hospitals across 17 states in the country. It has a presence abroad in Uganda and Nepal as well.

ASG Eye Hospital was established in 2005 by Dr. Arun Singhvi (Co-founder, promotor, Chairman, and Managing Director) and Dr. Shilpi Gang (Co-founder, promotor, and CEO) both of them are alumni of the prestigious All India Institute of Medical Science, New Delhi. The first hospital was established in Jodhpur city in Dec 2005 and has grown into one of the best eye care centers in India over the years.

Dr. Sony George, Dr. Sreeshankar, Dr. Amita Nair, Dr. Hima Jos, and Himanshu Mathur- Regional Operations Manager attended the press conference held in Kochi ASG Vasan Eye Hospitals.

4, May 2024
Aster Medcity Introduces Excimer Laser Angioplasty for Cardiovascular Patients

Aster Medcity Introduces Excimer Laser Angioplasty for Cardiovascular Patients

Kochi, 04 -May-2024: Aster Medcity launched the latest advancement in cardiovascular care with the introduction of Excimer Laser Angioplasty. This revolutionary technology of PLS Excimer Laser System marks a milestone in plaque modification for both Coronary and Peripheral Arteries, offering a comprehensive solution for patients with complex cardiovascular conditions.

The PLS Excimer Laser System stands out as the sole laser system with a broad spectrum of clinical indications, including to Lead Extraction Procedures. Utilizing a specially designed ELCA Catheter, this system facilitates the recanalization of occluded arteries, modifies lesion morphology, and optimizes treatment options, addressing the challenges faced by both patients and doctors. It is a clinically proven technology which is safe and is the only atherectomy equipment showing superiority in safety and efficacy with clinical evidence.

“Excimer Laser therapy provides solutions for various cardiovascular issues, including severe blood clots, challenging lesions, and balloon failure during conventional angioplasty procedures, “ said Dr. Anil Kumar R, Senior Consultant – Interventional Cardiology, Aster Medcity-Kochi.

Laser angioplasty offers several advantages, including higher success rates and better results in complex interventions, particularly beneficial in cases of highly thrombotic lesions by avoiding low reflow or no-reflow phenomena without the necessity for distal protective devices. It demonstrates significant improvement in instances of in-stent restenosis, often avoiding the need for a new stent insertion.

In addition to its primary applications, Laser angioplasty highly used for thrombotic lesions during percutaneous coronary intervention in acute myocardial infarction and acute coronary syndromes. It is a key tool for angioplasty of under-expanded stents and facilitates the modification of the proximal cap of calcified lesions that are otherwise challenging to cross with a wire. Similar blockages in peripheral arteries, carotids, and other vascular territories are addressed. It also plays a vital role in the extraction of previously implanted pacemaker leads

By emitting a cool beam of ultraviolet light with a wavelength of 308 nanometers, the Excimer Laser precisely breaks down, vaporizes, and removes arterial obstructions through pulsed photoablation, ensuring minimal tissue damage and maximal efficacy. In a laser angioplasty procedure, a catheter is inserted into an artery that emits advanced laser light ray that eliminates tough blockages in its path that could not have been achieved with conventional angioplasty. This procedure eliminates the conventional need for open-heart surgery in many patients, enhancing the quality of life for the patient, while also enabling the patient to go back home within 24 hours of the procedure.

“The latest model of the Excimer Laser system installed at Aster Medcity has enhanced features, including a smaller footprint, rapid readiness in less than 30 seconds, and touchscreen-guided workflow for seamless operability. This advancement enables its utilization even in acute myocardial infarction cases, delivering timely and precise cardiovascular care, said Dr. Rajasekhar Varma, Senior Consultant- Interventional Cardiology, Aster Medcity-Kochi.

“It is to be noted that Excimer Laser Angioplasty cardiovascular intervention, offers precision care, shorter hospital stays, and enhanced quality of life for patients”, commented Dr. Rajiv C, Senior Consultant – Interventional Cardiology , Aster Medcity-Kochi.

Farhaan Yasin- Aster India Vice President, Senior Consultants from the Interventional Cardiology, Aster Medcity- Dr. Anil Kumar R, Dr. Rajiv C and Dr. Rajasekhar Varma, and Consultant Dr. Sandeep R attended the press conference held in Kochi.

3, May 2024
Mother Suffering with NCPH and Hypersplenism Successfully Delivers Baby At BirthRight by Rainbow Hospitals

Rainbow

National, 3rd May 2024: BirthRight by Rainbow Hospitals, Financial District, and Star Hospitals, in a collaborative effort have showcased their expertise and dedication by ensuring successful childbirth for a woman battling Non-Cirrhotic Portal Hypertension (NCPH).

Dr. Himabindu Annamraju, a leading expert in maternal-fetal medicine at BirthRight, emphasizes that this recent success story highlights the crucial role played by coordinated clinical support in tackling complex medical conditions during pregnancy. The collaborative effort exemplifies the power of teamwork and specialized care in the realm of maternal health.

The patient, facing the challenges of NCPH, received expert care and attention from a multidisciplinary team. Through meticulous planning, advanced medical interventions, and constant monitoring, the team ensured a safe delivery and the birth of a healthy baby.

Diving into the details, a 30-year-old pregnant woman with Non-Cirrhotic Portal Hypertension (NCPH) came to the Star Hospitals at Financial District when she was 17 weeks into her pregnancy, presenting a complex medical challenge. During her assessment, doctors discovered she had grade 3 varices with RCS, an enlarged spleen, and a low platelet count of just 35,000. She was referred to BirthRight by Rainbow Hospitals for a safe delivery.

The multi-disciplinary team at Rainbow Children’s Hospital and BirthRight by Rainbow along with Star Hospitals, Financial District took on her case, assessing her condition and discussing the associated risks with her. They explained to her that she could face potential complications, including variceal bleeding, spontaneous abortion, and premature delivery.

The patient was prescribed beta blockers and was closely monitored throughout the pregnancy paying special attention to her coagulation levels, fetal heart rate, and the health of her baby.

As the pregnancy progressed, she eventually underwent a cesarean section. As liver conditions impact the bleeding factors and coagulation profile of the patient, this patient was carefully managed with the use of TEG to assess and provide necessary corrections to her coagulation and to control bleeding intra and post-operatively.

“She has been diagnosed with Non-Cirrhotic Portal Hypertension (NCPH) during pregnancy. The blood vessels in the liver become engorged, causing portal hypertension. This condition resulted in her spleen enlargement with dilated blood vessels over the food pipe, known as varices. Such patients are at high risk of bleeding or liver failure, compounded by the added complexity of pregnancy.”, noted Dr. Srinivasa Reddy, Consultant Hepatology & Liver Transplant Physician at Star Hospitals Financial District.

Dr. Himabindu Annamraju, a Senior Consultant in Obstetrics and Gynecology at BirthRight by Rainbow Hospitals, Financial District, who had dealt with the delivery said, “Ensuring a safe delivery for a patient with NCPH demands meticulous planning and teamwork. Pregnancy with liver disease is a complex condition requiring specialist medical care. This patient was at high risk of developing hypertension, pre-eclampsia, intrauterine growth restriction, and even in-utero fetal death. She was closely monitored during her pregnancy with regular blood tests and fetal scans for fetal well-being. She was educated on what symptoms to look out for and what red flags need immediate hospital attention. We ensured the safety of the mother and the baby, in this complex medical condition and we are thrilled that both mother and child are doing well.”

3, May 2024
Niswarth Kadam’s distributed milk in schools to foster Health and Well being

Health and Well being

Gurugram: Niswarth Kadam took a new initiative by distributing milk in Sector 92 located at Cluster School in their ongoing campaign Ek Kadam Neki Ki Aur. This initiative aimed to enhance the health and nutrition of school children. Recognizing the critical role that nutrition plays in the growth and development of young minds, Niswarth Kadam has taken a proactive step towards ensuring that every child has access to essential nutrients.

Regarding this initiative, Pramod Raghav, founder of Niswarth Kadam, says that milk is an important nutrient that is essential for our children. It provides them with high-quality nutrition and helps maintain their health. The main objective of this initiative is to make the children of our community healthy and nourished. This support is especially important for all those situations where children need proper nutrition but are unable to access it.

We believe that every child deserves access to nutritious food, regardless of their socio-economic background. By distributing milk in schools, we hope to empower students to lead healthier lives and achieve their full potential. Milk distribution program not only ensures the nutrition of the learners but it also impacts their studies. Healthy learners think positively and learn more.

2, May 2024
Unmasking Primary Immune Disorders: ACC spearheads raising awareness and the battle against PIDs

Unmasking Primary Immune Disorders: ACC spearheads raising awareness and the battle against PIDs

Chennai, May 2nd, 2024 – Apollo Cancer Centres (ACC) advocates raising awareness and addresses the challenges posed by the often-overlooked Primary Immunodeficiency Disorders (PIDs). In commemoration of the World Primary Immunodeficiency Week, observed from April 22nd to 29th, ACC spearheads discussions around this crucial health issue, shedding light on its prevalence and impact.

Primary Immunodeficiency Disorders represent a group of inherited conditions that compromise the body’s immune system, leaving individuals susceptible to infections. Shockingly, a significant portion of individuals with PIDs remain undiagnosed, leading to untreated complications and heightened risks. Despite the widespread impact of PIDs, there is alarmingly high mortality rates among affected infants, particularly those below one-year-old. Undiagnosed cases significantly contribute to this concerning statistic. While PIDs tends to be more severe in children, it can also affect adults, albeit with differing diagnostic challenges. In adults, the road to diagnosis may be prolonged, sometimes spanning up to 25 years from the onset of initial symptoms to an accurate PID diagnosis. This delay underscores the importance of heightened awareness and proactive screening initiatives to ensure timely medical intervention and improved outcomes for individuals affected by PID.

Over 6 million people globally suffer from PIDs, with an alarming 70-90% of cases remaining undiagnosed

(source:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7935502/#:~:text=Around%20the%20world%2C%20over%206%20million%20people,or%20more%20component%20of%20the%20immune%20system)

In India, where consanguineous marriages are prevalent, the incidence of PIDs is notably high, exacerbating the challenge. It is estimated that there could be more than one million patients with PID in India. Since PID is a genetic condition, there is a chance of every pregnancy being affected. Prenatal diagnosis or testing the foetus at 10 to 11 weeks for pregnancy can help detect whether the foetus is affected or not and families need to be counselled accordingly.

According to WHO (World Health Organization and IUIS (International Immunological Societies), over 120 Primary Immunodeficiency Disorders (PIDs) exist, with antibody deficiencies like CVID (Common Variable Immunodeficiency), and XLA (X-linked Agammaglobulinemia), topping the list.

(source: https://www.ipspiindia.org/about-pid)

Dr. Revathi Raj, Senior Consultant in Paediatric Haematology Oncology at Apollo Cancer Centre, Chennai, “PIDs, though often unnoticed, can significantly impact a child’s health. Early diagnosis and timely treatment of primary immune deficiencies can help these children to lead a good quality life. Awareness is not only important for treatment but also for prevention. We envision a future where every child with PID can lead a healthy and fulfilling life.”

Dr. Ramya Uppuluri, Consultant – Paediatric Haematology Oncology, emphasizes, “From cutting-edge diagnostics, including genetic testing and immunological assays, which play a pivotal role in accurately diagnosing PID, to advanced therapies like bone marrow transplantation, our comprehensive centre for PIDs is equipped with the expertise and resources to make a meaningful difference in the lives of those affected by PID”.

Dr Preetha Reddy, Executive Vice Chairperson, Apollo Hospitals Enterprise Ltd, said, “As we face the critical challenge of Primary Immune Disorders affecting millions, often in silence, Apollo Cancer Centres is committed to lighting the path forward. Awareness of these conditions is crucial, not only for effective treatment but also for prevention. By educating families and healthcare professionals, we aim to ensure early diagnosis and timely intervention, thus transforming the lives of countless children. Together, we are dedicated to a future where every child with PID can enjoy a healthy and fulfilling life”.

Fourteen-year-old Kavin, the PID warrior, said, “Battling constant infections was terrifying. Each cough and fever felt life-threatening. It wasn’t until Apollo Cancer Centre diagnosed and treated me for PIDs. Despite the fear, the medical team’s counselling provided immense comfort and I hope for a healthier future.”

Comprehensive Centre for PIDs at ACC is equipped with cutting-edge facilities, including a state-of-the-art Pediatric Intensive Care Unit (PICU), access to internationally acclaimed specialists in Pediatric Infectious Diseases and proficiency in PID diagnosis. ACC’s efforts extend beyond treatment to proactive measures such as genetic counselling for families with a history of PIDs, aimed at prevention at large. By nurturing awareness and facilitating early medical intervention, ACC strives to reshape the narrative surrounding Primary Immunodeficiency Disorders, ensuring a brighter future for affected children.

2, May 2024
Medica Superspecialty Hospital leads Eastern India in trauma care with successful inaugural ATLS course

 Medica Superspecialty Hospital leads

2nd May 2024 Kolkata: Medica Superspecialty Hospital, a leading healthcare institution in Eastern India, is proud to announce the successful hosting of its inaugural Advanced Trauma Life Support (ATLS) course from 28th April to 30th April’24. This significant initiative aligns with Medica’s steadfast commitment to bringing the highest standards of healthcare to Eastern India. Distinguished external faculty members for the inaugural course at Medica included Prof. Dr. MC Mishra, ATLS Chair and Program Director of ATLS India, along with Prof. Dr. Vinod Jain, Head Surgical Sciences, Neera Hospital, Lucknow, National Course Director ATLS India; Prof. Dr. Amita Ray, HOD Department of Obstetrics & Gynecology, MMC Medical College, Bihar and ATLS Senior Instructor, ATLS Educator India; and Dr (Brig.) Sanil Mohan, Head of Department, Department of Anesthesiology, Command Hospital (Eastern Command), Kolkata. Dr. Anirban Chatterjee, Senior Consultant, Hand & Pediatric Orthopedic Surgeon & Faculty – DNB Orthopedics, Medica Institute of Orthopaedic Sciences, In-house ATLS Instructor, Member of ATLS Team, Medica Superspecialty Hospital; Dr. Kasturi H. Bandyopadhyay, Senior Consultant Anaesthesiologist, DNB Faculty & ATLS Instructor, Medica Superspecialty Hospital and Dr. Akshay Gadre, Consultant Anaesthesiologist, DNB Faculty, ATLS Instructor and ATLS Site In Charge, Medica Superspecialty Hospital were an integral part of the ATLS course at Medica. The course was impeccably coordinated by Mr. Smith Banerjee, ATLS coordinator, Medica, Kolkata and Mr. Joseph Antony, Nursing Team Leader and Supervisor Emergency Medicine, ATLS Coordinator Medica, Kolkata under supervision from ATLS India head office.

Conducted under the esteemed banner of the American College of Surgeons, the ATLS course equips healthcare professionals with essential skills for managing polytrauma victims, particularly during the critical “Golden Hour” following injury. Developed out of the personal tragedy experienced by Orthopedic Surgeon Dr. James Styner in 1980, the ATLS program has gained global recognition as a pivotal method for training frontline providers in trauma patient care.

The initiative to introduce the ATLS course in India was spearheaded by the Indian Society for Trauma & Acute Care (ISTAC) with support from the Ministry of Health & Family Welfare and the National Disaster Management Authority of the Government of India. Since its inception at the Jai Prakash Narayan Apex Trauma Centre of AIIMS, New Delhi in 2009, numerous centers across India have embraced this training, significantly enhancing the preparedness of medical personnel to handle trauma cases effectively.

Dr. Anirban Chatterjee expressed, “The inaugural ATLS course at Medica Superspecialty Hospital marks a significant milestone in our journey. After a few years of effort, we’re proud to be the first hospital in Eastern India to host this course, joining 33 other centres across the country. This program holds profound significance as it equips physicians with the necessary knowledge and skills to deliver critical care to trauma patients. Through the ATLS course, doctors acquire vital insights and abilities to promptly identify and address life-threatening injuries amidst the intense pressures inherent in trauma care environments.”

While talking about the importance of the course, Dr. Kasturi H Bandyopadhyay, shared, “Our objective was to establish a dedicated trauma team for proficiently handling polytrauma cases within our hospital. Initiating this course marked our initial stride toward realizing this objective.”

Dr Akshay Gadre stated that, “Although limited to 16 delegates per course, as per ATLS guidelines and recommended instructor-provider ratio, we have received inquiries from Oman, Bangladesh, and Nepal, which we have enlisted for our subsequent sessions. Eligibility for participation mandates possession of an MBBS degree. Following the success of this endeavour, we have plans to extend our efforts to conduct the ATCN course, aimed at training nursing staff in proficient trauma care.”

Mr. R. Udayan Lahiry, Managing Director, Medica Group of Hospitals, told, “Trauma is a leading cause of death and disability all over the world. Trauma management can be improved by implementing a trauma care system that includes injury prevention, education, pre-hospital care, transportation, hospital care, and rehabilitation. If properly implemented, trauma system can reduce mortality by at least 10-15%. Training clinicians to manage trauma patients is an essential part of developing proper trauma systems. The primary end point of any clinical educational activity is its impact on improving health care delivery resulting in saving lives. At Medica, we have always reiterated on continuous education not only for our clinicians and nurses but also for all the caregivers of the region in the larger interest of the community we serve. We intend to initiate the ATCN course soon in our endeavour to address the trauma management holistically.”

Mr. Ayanabh Debgupta, Jt. Managing Director, Medica Group of Hospitals, shared, “Trauma globally results in six million deaths annually. Approximately 40 million people suffer permanent injuries each year, while up to 100 million experience temporary injuries. The UN and WHO/WHA highlight trauma as the primary cause of death among individuals aged five to 29 worldwide. Recent analysis conducted in Indian hospitals revealed that 58% of trauma-related deaths could have been prevented. Against this backdrop, the significance of the ATLS course is unparalleled, and it is imperative for all hospitals to establish trauma care teams to enhance patient outcomes.”

About Medica Group of Hospitals: Medica Group of Hospitals, one of the major chains of hospitals in Eastern India today, has built and managed numerous healthcare facilities across the Eastern region over the past few years. The group has footprints in West Bengal, Jharkhand, Odisha, Bihar, and Assam.

2, May 2024
Virinchi Hospitals Hosts Neonatal Resuscitation Workshop to Combat Oxygen-Related Neonatal Mortality

Virinchi Hospitals

Hyderabad,2nd May 2024: Virinchi Hospitals, a pioneer in healthcare services in Hyderabad, hosted a specialized workshop on Neonatal Resuscitation for the nursing staff, today at Virinchi Hospital, Banjara Hills. This vital program was organized by senior consultant Pediatrician Dr. Vannala Raju, with esteemed faculty members including Dr. Purna Guggilum, KIMS Cuddles; Dr. Vaddi Vamsi Krishna, Rainbow Children’s Hospital; and Dr. Raju himself.

The workshop focused on critical resuscitation techniques necessary for caring for newborns immediately after birth. More than 50 nursing professionals from various hospitals in & around the city participated in this engaging and informative session, acquiring skills that are crucial in reducing brain damage due to lack of oxygen immediately after birth (hypoxic-ischemic encephalopathy – HIE) —a common yet preventable threat to newborns.

India’s current neonatal mortality rate stands at approximately 20 deaths per 1,000 live births and conditions such as hypoxic-ischemic encephalopathy (HIE) because of poor cry/inability of the baby to breathe immediately after birth contribute significantly to neonatal deaths. It is estimated that 1.5 babies per 1,000 live births in India are affected by HIE, making it a crucial area for intervention.

Dr. Vannala Raju, who spearheaded the workshop, emphasized the importance of equipping nursing staff with the knowledge and techniques to administer immediate care. “Through this workshop, we aim to disseminate knowledge and skills to reduce neonatal mortality and enhance the quality of care provided right at the moment of birth,” said Dr. Raju.

The training covered a range of topics crucial to newborn care, including the effective management of breathing and cardiovascular stabilization. The workshop’s hands-on approach ensured that the nursing staff could practice and master these lifesaving techniques in a controlled, supportive environment.

The success of this program highlights Virinchi Hospitals’ commitment to advancing neonatal care and improving health outcomes for the youngest patients. The knowledge disseminated here is expected to significantly decrease the incidence of hypoxic damage and, by extension, neonatal mortality rates. Virinchi Hospitals continues to stand at the forefront of medical excellence and educational empowerment, aiming to set new standards in healthcare provision and staff training.

30, Apr 2024
Glocal Healthcare Systems Transforming Healthcare Dynamics in India

Innovative solutions are transforming healthcare delivery, especially in underserved regions where traditional models have struggled to provide accessible, affordable, and quality care. Leveraging technology and process optimization, some ventures are pioneering a new approach to healthcare. By integrating telemedicine, digital dispensaries, and acute care facilities, these initiatives aim to reach millions annually, even in remote areas. Their strategies involve reducing costs through efficient hospital designs and focusing on common diseases to improve clinical excellence. These efforts underscore a growing movement towards democratizing healthcare, ensuring that quality services are not just a privilege for the urban elite but a right for all.

Glocal Healthcare Systems, an innovative social venture founded by Dr. Sabahat Azim, is revolutionizing healthcare delivery in India’s underserved regions. With a focus on affordable, accessible, and accountable care, Glocal operates over 600 digital dispensaries and 11 acute care hospitals, serving more than 2 million patients annually. Originating from a personal tragedy experienced by Dr. Azim, Glocal was established with the ambition to overcome the challenges of traditional healthcare systems that fail to provide quality care, especially in rural areas.

Glocal’s approach to healthcare is significantly bolstered by technology and process optimization. Starting with a 30-bed hospital in West Bengal, the organization quickly expanded, perfecting a 100-bed hospital model ideal for Tier II/III cities, thanks to support from venture funding and impact investments. This growth reflects a strategic emphasis on treating a common subset of diseases with high clinical excellence, while also reducing construction and operational costs through innovative hospital design and management practices.

Innovation lies at the heart of Glocal’s mission. Dr. Azim advocates for a shift towards a process-based, standardized healthcare delivery system, akin to mass production principles. To this end, Glocal developed LitmusDX, a clinical decision support system powered by machine learning, which, along with LitmusMX and HelloLyf apps, facilitates efficient, remote patient care through digital dispensaries. These technologies ensure quality care is accessible even in the most remote areas, reducing medical errors and improving accountability.

30, Apr 2024
Oteria Skincare Launches Its Digital Brand Film To Drive Awareness On Circadian Rhythm For Better Skin

India, April 30, 2024: With its recent entry into the D2C skincare market, Rivpra Formulation’s skin care brand Oteria, today announced the launch of its new brand film, ‘Skincare Symphony with Circadian Rhythm Melody’. In a refreshing melodic spin, the film aims to advocate for holistic skincare practices based on the human body’s Circadian Rhythm, just like the symphonies of a song. Oteria, through its wide product portfolio, encourages customers to opt for skincare which doesn’t feel like a chore but instead allows them to nourish their skin through the day.

The film, conceptualised and produced by M&C Saatchi has been launched across Oteria’s digital platforms, playing to the tunes of one’s Circadian Rhythm and highlighting each product set to a different rhythm for a different time of the day for 24×7 skincare needs. Oteria’s #PlayingToSkin harnesses the power of Circadian Rhythm which plays a vital role in the overall skin health. The Circadian Rhythm is responsible for functions like cell turnover, collagen creation and UV protection, alongside combating other external stressors. Oteria, with its thoughtfully designed products, enables customers to have fun with skincare without the jargon it surrounds.

On the launch of the brand film, Vibhor Rastogi, Director, Rivpra Formulations & Oteria shared, “The film is set against the backdrop of a human body’s circadian rhythm and with Oteria, our goal is to heighten the awareness about skincare that suits the needs of one’s skin, 24×7. The film creatively plays to the rhythm of our day, highlighting the key products and ingredients that customers should be using to replenish their skin through the 4 essential zones of the day – such as the All Rounder Skin Cream and White Tea Face Wash for when you RISE, Radiant Kiwi Mist to revitalise your noon SHINE, Plumpy Skin Serum to unwind and CHILL and lastly Time Travel Under Eye Serum that helps to restore right before you YAWN.”

Furthering Oteria’s commitment, Aditi Jain, Marketing Head, Oteria, added, “As a brand, we take pride in providing gender-neutral holistic skincare solutions with a comprehensive approach to skin, hair and body care and the film is a testament to that commitment.”

Behind the visual storytelling, Gopal S Krishnan, Managing Director, M&C Saatchi February said, “The idea behind this film is to break away from the usual clutter of overloaded information, filled with jargons and terminologies, before and after feel, et al by the skincare industry. Oteria brand film brings the best of science and nature and makes skincare easy to understand and accessible to all genders. The film’s catchy melody effortlessly takes you through a person’s whole day, by simply following the body’s natural circadian rhythm by using the 4 simple routines of Oteria at the 4 times of the day. Grooving, dancing and singing the protagonist does it all! And gets the most effective results by simply using the right product at the right time. It is only an added pro that the harmony is fun and groovy!”

Following its debut in the D2C Skincare space, the brand launched 19 products and plans to launch 30 more products by 2026. With these product lines, the company is promoting skin awareness and education about one’s Circadian Rhythm. All Oteria products are available on e-commerce platforms like Amazon, Flipkart, and Oteria’s direct-to-consumer (D2C) platform, www.oteria.com.